Brainsway Ltd. American Depositary Shares (BWAY) — 分析摘要
Brainsway Ltd. American Depositary Shares（BWAY）的市值为578.72百万美元，最近一年的营收同比增长了+29.0%。净利润率为7.1%。当前市盈率为198.1倍。
核心要点
- 营收同比变化+29.0%
- 净利润率7.1%
- 市盈率198.1倍
BWAY的营收增长为+29.0%，市盈率为198.1倍。
Brainsway Ltd. American Depositary Shares (BWAY)
更新 — ET · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
利息保障倍数为 0.9x — 盈利不足以覆盖利息支出
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
员工人数
129
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。